CLINICAL_TRIALS
trial_result
· 2022-08-29
Clinical Trial Update: Safety Study of Oral Edaravone Administered in Subjects With ALS [Phase 3]
Summary
Phase 3 safety study of oral edaravone in people with amyotrophic lateral sclerosis has completed and results are posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Tanabe Pharma America, Inc. | Conditions: ALS | Phase 3 | Status: COMPLETED | Results posted: 2022-08-29